Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft

Sep.19.2024
Controversy Surrounding Indonesia's Tobacco and E-Cigarette Regulation Draft
Indonesia's Health Ministry is asked to suspend discussions on tobacco and e-cigarette safety regulations, sparking industry concerns.

According to a report from Metrotv News on September 18, the Indonesian Ministry of Health has been asked to suspend discussions on the draft of the 2024 Tobacco and E-cigarette Product Safety Regulation (RPMK). The regulation has been criticized for restricting the market space for tobacco and e-cigarette products, and potentially harming Indonesia's tobacco farming and tobacco industry chain.


According to reports, this suggestion was put forward during a national dialogue event held at the Ashley Hotel in Jakarta on September 17 by pesantren and the Community Development Center (P3M).


The event was attended by a total of 50 representatives from government agencies, farmers' associations, trade unions, retailers associations, businesses, tobacco industry associations, civil society alliances, academia, religious leaders, and media. P3M Director Sarmidi Husna expressed concerns about the RPMK 2024 draft primarily due to its proposed plain packaging regulations, which are seen as restrictive to the tobacco industry. Husna noted that there was insufficient public participation in the drafting process, making it unrepresentative.


Husna further explained that some provisions in the draft may cause harm to tobacco farmers, small and medium-sized enterprises, various associations, and the tobacco industry, triggering strong opposition from various parties.


Benguet Saragih, from the Disease Control Working Group at the Ministry of Health, clarified that RPMK 2024 is not aimed at getting people to quit smoking, but rather is intended to prevent children from smoking.


In response, the Chairman of the National Association of Islamic Scholars (PBNU), Miftah Faqih, emphasized that the process of formulating any laws must include a balanced participation from all parties and focus on the common good, otherwise these laws will be ineffective and unfair. The representative of the Ministry of Industry, Nugraha Prasetya Yogi, also stated that the Ministry of Industry was not included in the previous law-making process, which is very detrimental to trade and industry.


Union representative Sudarto pointed out that since the enactment of the 2003 Health Law and Government Regulation No. 28 of 2004, tobacco regulations have gradually been implemented, significantly impacting the tobacco leaf and tobacco products industry. Sudarto emphasized that industrial policies and tax policies have also been used to suppress legal tobacco consumption, leading to the frequent appearance of illegal tobacco products.


Gunawan from the Indonesian Commission for Social Justice and Human Rights (IHCS) is calling for the coordination of existing regulations and laws to protect the interests of tobacco farmers. Indonesian parliament member Muhammad Misbakhun mentioned that the influence of international giants has caused local economies and tobacco farmers to go bankrupt, and therefore calls for the government to be a facilitator in finding a solution to the problem.


Representatives from the Indonesian Tobacco Association, Budiman, believe that restricting the sale of tobacco products will have negative effects on production, employment, and raw material sourcing. Additionally, Kusnasi Mudi, the Secretary General of the National Tobacco Growers Association (APTI), also stated that the government needs to reexamine this regulation and communicate with the entire industry chain to prevent significant impact on the future development of the industry.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
Product | KT&G to Launch lil Tonino Lamborghini in South Korea, Bringing 3-Second Heat-Up to New HTP Platform
Product | KT&G to Launch lil Tonino Lamborghini in South Korea, Bringing 3-Second Heat-Up to New HTP Platform
KT&G will launch the lil Tonino Lamborghini heated tobacco device in Seoul on September 15, 2026. The product introduces a new heating technology called Flashwave Heating, which uses microwaves to heat tobacco sticks internally and delivers a manufacturer-rated heat-up time of about three seconds. The device features an all-metal aluminum body, a color display and a dedicated GUI, and launches alongside a new line of NAU tobacco sticks that are incompatible with existing lil consumables. Korean media describe the product as KT&G's first new heated tobacco platform since lil AIBLE was introduced in 2022.
Aug.31
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28